Wall Street analysts predict that Exponent, Inc. (NASDAQ:EXPO) will post $78.45 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Exponent’s earnings. The lowest sales estimate is $77.80 million and the highest is $79.10 million. Exponent posted sales of $72.75 million during the same quarter last year, which suggests a positive year over year growth rate of 7.8%. The company is scheduled to report its next quarterly earnings report on Wednesday, February 7th.

According to Zacks, analysts expect that Exponent will report full-year sales of $78.45 million for the current financial year, with estimates ranging from $324.75 million to $326.10 million. For the next financial year, analysts forecast that the business will report sales of $335.96 million per share, with estimates ranging from $331.41 million to $340.50 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover Exponent.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Wednesday, October 18th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $0.09. The company had revenue of $87.60 million during the quarter, compared to analyst estimates of $79.69 million. Exponent had a net margin of 16.46% and a return on equity of 17.21%. Exponent’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned $0.42 EPS.

EXPO has been the topic of a number of recent analyst reports. Cantor Fitzgerald raised their price objective on shares of Exponent to $82.00 and gave the stock an “overweight” rating in a report on Thursday, October 19th. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a report on Friday, October 20th. BidaskClub cut shares of Exponent from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, SunTrust Banks restated a “hold” rating and set a $77.00 target price on shares of Exponent in a research note on Thursday, October 19th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Exponent presently has an average rating of “Hold” and an average price target of $80.00.

In related news, CEO Paul R. Johnston sold 3,696 shares of Exponent stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $70.86, for a total value of $261,898.56. Following the completion of the sale, the chief executive officer now directly owns 42,394 shares in the company, valued at $3,004,038.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Paul R. Johnston sold 4,000 shares of Exponent stock in a transaction dated Thursday, September 21st. The shares were sold at an average price of $72.42, for a total value of $289,680.00. Following the completion of the sale, the chief executive officer now owns 38,394 shares of the company’s stock, valued at $2,780,493.48. The disclosure for this sale can be found here. Insiders have sold 13,748 shares of company stock valued at $996,740 over the last ninety days. 2.80% of the stock is owned by insiders.

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its holdings in shares of Exponent by 3.9% during the second quarter. Vanguard Group Inc. now owns 2,261,432 shares of the business services provider’s stock valued at $131,841,000 after acquiring an additional 85,291 shares in the last quarter. Conestoga Capital Advisors LLC increased its holdings in shares of Exponent by 17.5% during the third quarter. Conestoga Capital Advisors LLC now owns 854,790 shares of the business services provider’s stock valued at $63,169,000 after acquiring an additional 127,613 shares in the last quarter. State Street Corp increased its holdings in shares of Exponent by 4.5% during the second quarter. State Street Corp now owns 642,196 shares of the business services provider’s stock valued at $37,436,000 after acquiring an additional 27,930 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Exponent by 43.8% during the second quarter. Renaissance Technologies LLC now owns 530,700 shares of the business services provider’s stock valued at $30,940,000 after acquiring an additional 161,600 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Exponent by 2.0% during the second quarter. Northern Trust Corp now owns 478,610 shares of the business services provider’s stock valued at $27,903,000 after acquiring an additional 9,593 shares in the last quarter. Institutional investors and hedge funds own 88.61% of the company’s stock.

Shares of Exponent (EXPO) opened at $71.90 on Wednesday. The stock has a market cap of $1,886.77, a PE ratio of 39.94 and a beta of 0.57. Exponent has a 1-year low of $55.75 and a 1-year high of $77.15.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Friday, December 1st will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.17%. The ex-dividend date is Thursday, November 30th. Exponent’s payout ratio is 40.98%.

ILLEGAL ACTIVITY WARNING: “$78.45 Million in Sales Expected for Exponent, Inc. (EXPO) This Quarter” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/12/13/78-45-million-in-sales-expected-for-exponent-inc-expo-this-quarter.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.